Anticoagulation in Venous Thromboembolism Prophylaxis in Medically Ill Patients: Potential Impact of NOACs

被引：1

作者：

Knotts, Tara L. ^{[1
]}

Mousa, Shaker A. ^{[1
]}

机构：

[1] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, 1 Discovery Dr, Rensselaer, NY 12144 USA

来源：

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 2019年 / 19卷 / 04期

关键词：

EXTENDED-DURATION BETRIXABAN; FACTOR XA INHIBITOR; ACUTELY ILL; HOSPITALIZED-PATIENTS; ORAL ANTICOAGULANTS; AMERICAN-COLLEGE; APEX TRIAL; PREVENTION; RISK; THROMBOPROPHYLAXIS;

D O I：

10.1007/s40256-019-00329-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

While substantial evidence supports the use of standard-duration injectable anticoagulants for venous thromboembolism (VTE) prophylaxis, consensus is mixed about which agents may be preferred in acutely ill patients with ongoing need of VTE prophylaxis past the first 10-day duration of hospital stay and post-discharge. Non-vitamin K antagonist oral anticoagulants (NOACs) provide Factor Xa inhibition to prevent the thrombin generation essential in thromboembolism development, but evidence for the efficacy and safety of most NOACs is conflicting regarding extended-duration prophylaxis. Enoxaparin, a preferred injectable anticoagulant in standard-duration VTE prophylaxis, has shown an increased risk of major bleeding events when used in extended-duration prophylaxis, which outweighs its benefit. Rivaroxaban has demonstrated efficacy in extended-duration prophylaxis, but both rivaroxaban and apixaban have shown increased risks of major bleeding. Betrixaban remains the only NOAC approved in the USA for extended-duration VTE prophylaxis, and it demonstrates efficacy, with fewer adverse effects than other NOACs. This review evaluates the appropriateness of different NOAC agents compared with current therapies for the extended-duration VTE prophylaxis setting in medically ill populations.

引用

页码：365 / 376

页数：12

共 50 条

[21]

Davis PJ, 2018, CLIN APPL THROMB-HEM, V1, P1

[22] Factors at Admission Associated With Bleeding Risk in Medical Patients Findings From the IMPROVE Investigators [J].

Decousus, Herve ;

Tapson, Victor F. ;

Bergmann, Jean-Francois ;

Chong, Beng H. ;

Froehlich, James B. ;

Kakkar, Ajay K. ;

Merli, Geno J. ;

Monreal, Manuel ;

Nakamura, Mashio ;

Pavanello, Ricardo ;

Pini, Mario ;

Piovella, Franco ;

Spencer, Frederick A. ;

Spyropoulos, Alex C. ;

Turpie, Alexander G. G. ;

Zotz, Rainer B. ;

FitzGerald, Gordon ;

Anderson, Frederick A. .

CHEST, 2011, 139 (01) :69-79

[23] Anticoagulant therapy for venous thromboembolism prophylaxis in orthopaedic surgery in Japan: The evolving role of NOACs [J].

Fuji, Takeshi .

CURRENT ORTHOPAEDIC PRACTICE, 2016, 27 (06) :666-672

[24] Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients [J].

Gibson, C. Michael ;

Nafee, Tarek ;

Yee, Megan K. ;

Chi, Gerald ;

Korjian, Serge ;

Daaboul, Yazan ;

AlKhalfan, Fahad ;

Kerneis, Mathieu ;

Goldhaber, Samuel Z. ;

Hull, Russel ;

Hernandez, Adrian F. ;

Cohen, Alexander T. ;

Harrington, Robert A. .

AMERICAN HEART JOURNAL, 2018, 198 :84-90

[25] Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy [J].

Gibson, C. Michael ;

Korjian, Serge ;

Chi, Gerald ;

Daaboul, Yazan ;

Jain, Purva ;

Arbetter, Douglas ;

Goldhaber, Samuel Z. ;

Hull, Russel ;

Hernandez, Adrian F. ;

Lopes, Renato D. ;

Gold, Alex ;

Cohen, Alexander T. ;

Harrington, Robert A. ;

Bello, F. ;

Ferrari, A. E. ;

Jure, H. ;

Macin, S. ;

Oliva, M. ;

Parody, M. ;

Poy, C. ;

Baker, R. ;

Coughlin, P. ;

Finfer, S. ;

Rubinfeld, A. ;

Huber, K. ;

Konig, J. ;

Mathies, R. ;

Schoenerr, H. ;

Adzerikho, I. ;

Koryk, V. ;

Mikhailova, E. ;

Mitkovskaya, N. ;

Pimanov, S. ;

Polonetsy, L. ;

Soroka, N. ;

Blockmans, D. ;

Delforge, M. ;

Dive, A. ;

Lienart, F. ;

Bizzacchi, J. Annichino ;

Fiss, E. ;

Freire, A. ;

Manenti, E. ;

Ramacciotti, E. ;

Raymuno, S. ;

Rocha, A. ;

Dimov, B. ;

Grigorov, M. ;

Kalpachki, R. ;

Kamenova, Z. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07)

[26] The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial [J].

Gibson, C. Michael ;

Halaby, Rim ;

Korjian, Serge ;

Daaboul, Yazan ;

Arbetter, Douglas F. ;

Yee, Megan K. ;

Goldhaber, Samuel Z. ;

Hull, Russel ;

Hernandez, Adrian F. ;

Lu, Shiao-ping ;

Bandman, Olga ;

Leeds, Janet M. ;

Gold, Alex ;

Harrington, Robert A. ;

Cohen, Alexander T. ;

Bello, F. ;

Ferrari, A. E. ;

Jure, H. ;

Macin, S. ;

Oliva, M. ;

Parody, M. ;

Poy, C. ;

Baker, R. ;

Coughlin, P. ;

Finfer, S. ;

Rubinfeld, A. ;

Huber, K. ;

Konig, J. ;

Mathies, R. ;

Schoenerr, H. ;

Adzerikho, I. ;

Koryk, V. ;

Mikhailova, E. ;

Mitkovskaya, N. ;

Pimanov, S. ;

Polonetsy, L. ;

Soroka, N. ;

Blockmans, D. ;

Delforge, M. ;

Dive, A. ;

Lienart, F. ;

Bizzacchi, J. Annichino ;

Fiss, E. ;

Freire, A. ;

Manenti, E. ;

Ramacciotti, E. ;

Raymuno, S. ;

Rocha, A. ;

Dimov, B. ;

Grigorov, M. .

AMERICAN HEART JOURNAL, 2017, 185 :93-100

[27] Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients [J].

Goldhaber, Samuel Z. ;

Leizorovicz, Alain ;

Kakkar, Ajay K. ;

Haas, Sylvia K. ;

Merli, Geno ;

Knabb, Robert M. ;

Weitz, Jeffrey I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23) :2167-2177

[28] Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Gould, Michael K. ;

Garcia, David A. ;

Wren, Sherry M. ;

Karanicolas, Paul J. ;

Arcelus, Juan I. ;

Heit, John A. ;

Samama, Charles M. .

CHEST, 2012, 141 (02) :E227S-E277S

[29] Executive Summary Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Guyatt, Gordon H. ;

Akl, Elie A. ;

Crowther, Mark ;

Gutterman, David D. ;

Schuenemann, Holger J. .

CHEST, 2012, 141 (02) :7S-47S

[30]

Heit JA, 2005, BLOOD, V106, p267A

← 1 2 3 4 5 →